Evaluation of recombinant DNA-directed E.coli produced α1-antitrypsin as an anti-neutrophil elastase for potential use as replacement therapy of α1-antitrypsin deficiency
- 31 July 1985
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 130 (3), 1177-1184
- https://doi.org/10.1016/0006-291x(85)91739-5
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Synthesis in yeast of a functional oxidation-resistant mutant of human α1-antitrypsinNature, 1984
- A simple one-step purification of human α1-proteinase inhibitor by immunoadsorbent column chromatographyJournal of Biochemical and Biophysical Methods, 1981
- Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.JCI Insight, 1981
- Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.JCI Insight, 1981
- Active site of α1-antitrypsin: Homologous site in antithrombin-IIIBiochemical and Biophysical Research Communications, 1980
- Properties of Isolated Human alpha1-Antitrypsins of Pi Types M, S and ZEuropean Journal of Biochemistry, 1978
- Natural History and Life Expectancy in Severe Alpha1‐Antitrypsin Deficiency, Pi ZActa Medica Scandinavica, 1978
- On the inhibition of elastase by serum. Some distinguishing properties of α1-antitrypsin and α2-macroglobulinClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- Isolation and properties of human plasma α-1-proteinase inhibitorBiochemistry, 1974
- [2] Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HClPublished by Elsevier ,1970